Showing results (291-300 of 361) with videos related to

Sort By:
Pageof 37
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 6, 2020
Integration of patient-reported outcomes (PROs) for personalized symptom management in "real-world" oncology practices: a population-based cohort comparison study of impact on healthcare utilizationDoris Howell, Madeline Li, Rinku Sutradhar, et al.
CMAJ Open|May 31, 2022
Opportunistic salpingectomy between 2011 and 2016: a descriptive analysisGillian E Hanley, Jin Niu, Jihee Han, et al.
Clinical Colorectal Cancer|October 10, 2006
Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancerBrian M Wolpin, Jeffrey W Clark, Jeffrey A Meyerhardt, et al.
Cancer Investigation|October 10, 2003
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancerDavid P Ryan, Jeffrey W Clark, Matthew H Kulke, et al.
Cancers|September 28, 2024
Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation ProjectSoo-Jin Seung, Nicole Mittmann, Zharmaine Ante, et al.
The Lancet. Oncology|September 3, 2021
Transforming Canada's role in global cancer controlDanielle Rodin, Anna J Dare, Reanne Booker, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 9, 2021
The cost of chemotherapy administration: a systematic review and meta-analysisGursharan K Sohi, Jordan Levy, Victoria Delibasic, et al.
Journal of the National Cancer Institute|February 2, 2006
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patientsCraig C Earle, Deborah Schrag, Bridget A Neville, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuationT P Hanna, T Baetz, J Xu, et al.
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
Pageof 37